Novonesis AS

Legal Proceedings Report • Oct 27, 2011

October 27, 2011

Jury decides in Novozymes' favor in US patent law suit against Danisco

Jury has found Danisco liable for infringing Novozymes' US Patent No. 7,713,723 on alpha-amylases for use in the biofuel and starch industries.

A jury in the US District Court for the Western District of Wisconsin found Novozymes' US Patent No. 7,713,723 valid and ordered Danisco to pay damages of USD 18,290,500 for infringement. The jury also found Danisco's infringement to be willful.

The jury's decision is not the final verdict. The decision is subject to the judge's affirmation and possible appeals, the timing of which is at the courts' discretion.

Novozymes' patent covers certain alpha-amylase enzymes for use in the biofuel and starch industries. The infringing products have primarily been used to produce ethanol from corn starch in the US.

Novozymes filed the lawsuit against Danisco in May 2010.

Danisco was acquired by DuPont earlier this year.

Contact persons: Press and media: Investor relations: Johan Melchior (Europe) Tel. (direct): +45 4446 0690 Tel. (mobile): +45 3077 0690

Tobias Bjorklund Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682

Martin Riise Nielsen Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement no. 64, 2011 Page 1 of 1 Novozymes A/S Investor Relations Luna-no. 2011-27659-01

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27